Moderna falls short of sales and earnings expectations in the third quarter | Video | CNN

The biotech company Moderna fell short of third-quarter earnings and sales expectations.

Moderna reported that it earned $ 3.3 billion and had revenues of $ 5 billion in the quarter.

The company warned that shipments of its covid-19 vaccine will not meet its forecasts for the rest of the year.